Interleukin-6 and C-reactive protein prognostic value following acute coronary syndrome

Journal:

European Heart Journal

Published:

2026-05-26

DOI:

10.1093/eurheartj/ehag317

Affiliations:

20

Authors:

14

Go to article

Institutions	Authors	Share
Leiden University Medical Center (LUMC), Netherlands	2.500000	0.18
Mount Sinai Heart, United States of America (USA)	1.250000	0.09
University of Colorado Anschutz Medical Campus (CU Anschutz), United States of America (USA)	1.250000	0.09
The University of Alabama at Birmingham (UAB), United States of America (USA)	1.000000	0.07
Roche, Switzerland	1.000000	0.07
Regeneron Pharmaceuticals, United States of America (USA)	1.000000	0.07
Weill Cornell Medicine, United States of America (USA)	1.000000	0.07
Sanofi, France	1.000000	0.07
ICIN - Netherlands Heart Institute, KNAW, Netherlands	0.500000	0.04
Health New Zealand Auckland, New Zealand	0.500000	0.04
The University of Auckland, New Zealand	0.500000	0.04
Canadian VIGOUR Centre, U of A, Canada	0.333333	0.02
St. Michael's Hospital, Canada	0.333333	0.02
University of Toronto (U of T), Canada	0.333333	0.02
SUNY Downstate Health Sciences University (SUNY Downstate), United States of America (USA)	0.250000	0.02
CPC Clinical Research, United States of America (USA)	0.250000	0.02
Laboratory for Vascular Translational Science (LVTS), France	0.250000	0.02
French Clinical Research Infrastructure Network (F-CRIN), France	0.250000	0.02
French Alliance for Cardiovascular Trials (FACT), France	0.250000	0.02
Assistance Publique-Hôpitaux de Paris (AP-HP), France	0.250000	0.02

Interested in Cardiovascular Medicine and Haematology?